Jim O'Neill is an American science and technology investor whom President-elect Donald Trump has selected to serve as United States Deputy Secretary of Health and Human Services.
Prior, he was a managing director at Peter Thiel's Mithril Capital in Silicon Valley, and served as CEO of SENS Research Foundation until his departure in July 2021.
O'Neill has been a frequent critic of the Food and Drug Administration (FDA), and was considered by Trump to lead the administration during his first presidential transition.
O'Neill attended Yale University from 1986 to 1990, receiving a B.A. in Humanities. He proceeded to the University of Chicago, where he studied from 1996 to 1997, earning an A.M. in Humanities.
He was Associate Deputy Secretary and Senior Advisor to the Deputy Secretary of HHS from August 2005 to November 2007,[5] where he was involved in policy formulation for various HHS components.
He then served as Principal Associate Deputy Secretary of HHS from November 2007 to October 2008, where he provided advice on policy and programming, helped manage HHS, and his policy portfolio focused on FDA, NIH, AHRQ, the Office of Public Health and Science, BARDA, global health, and the President's Management Agenda.
Prior to working at Mithril Capital, O'Neill was managing director of Clarium Capital.
Norb Leahy, Dunwoody GA Tea Party Leader
No comments:
Post a Comment